A Cuproptosis-Related lncRNAs Signature Could Accurately Predict Prognosis in Patients with Clear Cell Renal Cell Carcinoma

Figure 5

Validation of risk signature power and independent prognostic factors. (a), (c), and (e) Uni-Cox and (b), (d), and (f) multi-Cox analysis of clinicopathological factors and the risk scores in the training set, testing set, and the whole set. (g) The area under the curve (AUC) and the receiver operating characteristic (ROC) curves of different factors. (h) The AUC under the 1-, 3-, and 5-year ROC curves of risk scores.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)